Related references
Note: Only part of the references are listed.From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic Cancers
Ioannis D. Kyrochristos et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer
Takashi Sasaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2013)
A Retrospective Study of Gemcitabine and Cisplatin Combination Therapy as Second-Line Treatment for Advanced Biliary Tract Cancer
Takashi Sasaki et al.
CHEMOTHERAPY (2013)
Optimal sample sizes for phase II clinical trials and pilot studies
Nigel Stallard
STATISTICS IN MEDICINE (2012)
Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapy
Takashi Sasaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer
Masashi Kanai et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202
Syma Iqbal et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Phase II study of second line gemcitabine single chemotherapy for biliary tract cancer patients with 5-fluorouracil refractoriness
Sung Yong Oh et al.
INVESTIGATIONAL NEW DRUGS (2011)
Feasibility study of gemcitabine and cisplatin combination chemotherapy for patients with refractory biliary tract cancer
Takashi Sasaki et al.
INVESTIGATIONAL NEW DRUGS (2011)
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
T. Okusaka et al.
BRITISH JOURNAL OF CANCER (2010)
Multicenter, phase II study of gemcitabine and S-1 combination chemotherapy in patients with advanced biliary tract cancer
Takashi Sasaki et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Second-Line Treatment With a Combination of Continuous 5-Fluorouracil, Doxorubicin, and Mitomycin-C (Conti-Fam) in Gemcitabine-Pretreated Pancreatic and Biliary Tract Cancer
Suee Lee et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2009)
Epidemiology of biliary tract cancers: an update
G. Randi et al.
ANNALS OF ONCOLOGY (2009)
Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers
Maria S. Pino et al.
ONCOLOGY (2009)
S-1 monotherapy as first-line treatment in patients with advanced biliary tract cancer: a multicenter phase II study
Junji Furuse et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer
Rachel R. Riechelmann et al.
CANCER (2007)
Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials
F. Eckel et al.
BRITISH JOURNAL OF CANCER (2007)
Cetuximab plus gemcitabine-oxaliplatin (GEMOX) in patients with refractory advanced intrahepatic cholangiocarcinomas
Bernard Paule et al.
ONCOLOGY (2007)
International comparisons of cumulative risk of gallbladder cancer and other biliary tract cancer, from cancer incidence in five continents vol. VIII
Tomohiro Matsuda et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2007)
Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma
JY Cho et al.
CANCER (2005)
Combining gemcitabine and capecitabine in patients with advanced biliary cancer: A phase II trial
JJ Knox et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Biliary tract cancers: current concepts and controversies
GD Leonard et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Gemcitabine, 5-fluorouracil, and leucovorin in advanced biliary tract and gallbladder carcinoma - A north central cancer treatment group phase II trial
SR Alberts et al.
CANCER (2005)
Cholangiocarcinoma: Current concepts and insights
GJ Gores
HEPATOLOGY (2003)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
